Phase 1 Cryopyrin-Associated Periodic Syndromes Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

AmyloidosisCryopyrin-Associated Periodic Syndromes

National Institute of Allergy and Infectious Diseases (NIAID)30 enrolled1 locationNCT06974877

Recruiting

Phase 1

Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Cryopyrin-associated Periodic Syndromes (CAPS)

Akros Pharma Inc.5 enrolled1 locationNCT07247266